title: Congenital nephrotic syndrome.
abstract: Congenital nephrotic syndrome (CNS) is a rare kidney disorder characterized by heavy proteinuria, hypoproteinemia, and edema starting soon after birth. The majority of cases are caused by genetic defects in the components of the glomerular filtration barrier, especially nephrin and podocin. CNS may also be a part of a more generalized syndrome or caused by a perinatal infection. Immunosuppressive medication is not helpful in the genetic forms of CNS, and kidney transplantation is the only curative therapy. Before the operation, management of these infants largely depends on the magnitude of proteinuria. In severe cases, daily albumin infusions are required to prevent life-threatening edema. The therapy also includes hypercaloric diet, thyroxin and mineral substitution, prevention of thrombotic episodes, and prompt management of infectious complications. The outcome of CNS patients without major extrarenal manifestations is comparable with other patient groups after kidney transplantation.
authors.affiliation: Hospital for Children and Adolescents, University of Helsinki, Finland. hannu.jalanko@hus.fi
authors.forename: Hannu
authors.initials: H
authors.lastname: Jalanko
mesh_terms: D006801:Humans; D047908:Intracellular Signaling Peptides and Proteins / Q000235:genetics; D016030:Kidney Transplantation / Q000009:adverse effects*; D008565:Membrane Proteins / Q000235:genetics; D009404:Nephrotic Syndrome / Q000151:congenital*; D050199:Podocytes / Q000378:metabolism
chemical_list: D047908:Intracellular Signaling Peptides and Proteins; D008565:Membrane Proteins; C407223:NPHS2 protein; C113267:nephrin